1.Development of University of Wisconsin (UW) solution in pancreatic transplantation
International Journal of Surgery 2008;35(9):607-609
The incidence of diabetes has a rapid increase trend trend in the whole world. In China, the incidence has come to 3%. The most of patients with type Ⅰ and part of type Ⅱ diabetes rely on exogenious insulin to control blood glucose;they not only have to bear the uncomfortbleness of insulin injection, but also inevitably to face the forward complications, so,the main concern in recent years is to rebuild the endogenous insulin secretion system. Many experiments show that pancreas transplantation not only can stop the development of insulin dependent diabe-tes, but also revert the already existing complications, just like with other organ transplants, the organ access and preservation is prerequisite for success. Because of the specificity of pancreas tissue, the effects of different organ preservation solution for the preservation of the pancreas varies. In this paper we will talk about the effect of UW preservation solution in the pancreas transplantation.
2.Progress in the study of Her2-targeted cancer therapeutic antibodies.
Liang CHANG ; Chen-hui LI ; Jian GAO
Acta Pharmaceutica Sinica 2015;50(5):516-520
Tumor surface antigen human epidermal growth factor receptor 2 (Her2) is a type I receptor tyrosine kinase, which belongs to human epidermal growth factor receptor family. Her2-overexpression is associated with tumorigenesis and metastasis. Due to significant clinical effects, Her2-targeted cancer therapy especially therapeutic antibody has become the hot spot in the field of cancer treatment. Anti-Her2 antibody drugs include monoclonal antibodies, antibody-drug conjugates, bispecific antibodies and emerging "two in one" antibody. Based on structure and function of Her2, this review focuses on recent advances in active mechanisms and clinical researches of these antibodies.
Antibodies, Bispecific
;
therapeutic use
;
Antibodies, Monoclonal
;
therapeutic use
;
Humans
;
Immunoconjugates
;
therapeutic use
;
Neoplasms
;
drug therapy
;
Receptor, ErbB-2
;
immunology
5.The function of HGF/SF in the proliferation of colorectal cancer cells
Hongwu LI ; Qu ZHANG ; Jian LIANG
Chinese Journal of General Surgery 1993;0(02):-
Objective To study the function of hepatocyte growth factor/scatter factor(HGF/SF) in the (proliferation) of colorectal cancer cells.Methods The expression of c-met,the receptor of HGF,was(detected) in Caco-2 and Colo320 cell lines by Western blot.The activation of p42/p44MAPK and p38MAPK induced by HGF in these two cell lines was observed.Observation of the effect of the inhibitor of p42/p44MAPK(PD98059),p38MAPK(SB203580) on the inhibition of HGF-induced proliferation of Caco-2 and Colo320 cells were made by Using -TdR,MTT assay.Results(1)Both cell lines(expressed) the c-met.(2)HGF activated p42/p44MAPK and p38MAPK,and 20ng/ml HGF treated cells showed maximum activity in both to be within 10min.(p42/p44MAPK,2.28?0.01;p38MAPK,2.25?0.01).(3)HGF was found to significantly increase thymidine incorporation(P
6.The treatment options for retinoblastoma
Jian-Hong LIANG ; Xiao-Xin LI ;
Ophthalmology in China 2006;0(06):-
Treatment options of retinoblastoma should be individualized. Patients with early intraocular stage may be managed with focal treatments, including cryotherapy, thermotherapy, laser photocoagulation, brachytherapy and so on. Patients with middle in- traocular stage may be treated with chemoreduction plus focal therapy. In patients with advanced stage, enucleation and chemotherapy are recommended, with the addition of orbital radiation for patients with extraocular retinoblastoma. Patients with systemic metastases require intensive chemotherapy and consolidation with autologous hematopoietic stem cell rescue.
7.Expression and significance of survivin and cyclin D_1 in hepatic cellular carcinoma.
Jian LIANG ; Kaihong HUANG ; Haigang LI
Chinese Journal of Practical Internal Medicine 2001;0(03):-
Objective To study the expression and significance of survivin and cyclin D 1 in hepatic cellular carcinoma (HCC).Methods The expression of survivin and cyclin D 1 were detected in 61 cases of HCC by immunohistochemistry.Results The expressive rates of survivin and cyclin D 1 in HCC were 44.3% and 39.3%.Both survivin and cyclin D 1 rates in the lower-differentiated group were significantly higher than those in the well-differentiated (P
8.Clinical assessment of one-visit root canal therapy for vital teeth
jian-hui, DONG ; guo-liang, LI
Journal of Shanghai Jiaotong University(Medical Science) 2006;0(07):-
0.05).It was revealed that all the patients followed up 3 to 6 months after treatment were free from complaints of the involved teeth,with nomal food intake and mastication.No abnormal adjacent tissues of dental roots were detected by imaging examination.Conclusion For the vital teeth,the similar clinical effect may be obtained by one-visit RCT and multi-visit RCT.
9.Progress in the study of Her2-targeted cancer therapeutic antibodies.
Liang CHANG ; Chenhui LI ; Jian GAO
Acta Pharmaceutica Sinica 2015;50(5):516-20
Tumor surface antigen human epidermal growth factor receptor 2 (Her2) is a type I receptor tyrosine kinase, which belongs to human epidermal growth factor receptor family. Her2-overexpression is associated with tumorigenesis and metastasis. Due to significant clinical effects, Her2-targeted cancer therapy especially therapeutic antibody has become the hot spot in the field of cancer treatment. Anti-Her2 antibody drugs include monoclonal antibodies, antibody-drug conjugates, bispecific antibodies and emerging "two in one" antibody. Based on structure and function of Her2, this review focuses on recent advances in active mechanisms and clinical researches of these antibodies.
10.Clinical effectiveness of incision-thread-drawing procedure for perianal abscess
Chunyu LI ; Min NIE ; Jian LIANG
Chinese Journal of General Practitioners 2005;0(11):-
Objective To compare the clinical effectiveness of incision-thread-drawing procedure and incision and drainage procedure in the treatment of perianal abscess.Methods Clinical data collected from 110 patients with perianal abscess were retrospectively analyzed.Forty-six cases were treated with incision-thread-drawing procedure(therapy group) and 64 with incision and drainage procedure(control group).Results Recurrence rate and incidence of anal fistula were 4%(2/46) and 4%(2/46) in therapy group,respectively,significantly lower than those in control group(19% and 23%,P